Page 68 - MJHP MALAYSIAN JOURNAL OF HEALTH PROMOTION Volume 2, 2020

MALAYSIAN JOURNAL OF HEALTH PROMOTION Volume 2, 2020

Bukenya, D., Mayanja, B. N., Nakamanya, S., Muhumuza, R., & Seeley, J.
(2019). What causes non-adherence among some individuals on long
term antiretroviral therapy? Experiences of individuals with poor viral
suppression in Uganda. AIDS Research and Therapy, 16(1), 2. https://doi.
org/10.1186/s12981-018-0214-y
Burrell, C., & Levy, R. (1984). Therapeutic consequences of noncompliance.
Improving Medication Compliance, 7–16.
Choy, K. K. (2017). Malaysian Consesus Guidelines on Antiretroviral Therapy
2017. Ministry of Health Malaysia.
Clifton, D. A., Wong, D., Clifton, L., Wilson, S., Way, R., Pullinger, R., &
Tarassenko, L. (2013). A large-scale clinical validation of an integrated
monitoring system in the Emergency Department. IEEE Journal
of Biomedical and Health Informatics, 17(4), 835–842. https://doi.
org/10.1109/JBHI.2012.2234130
Friedland, G. H., & Williams, A. (1999). Attaining Higher Goals in HIV
Treatment: The Central Importance of Adherence. AIDS (London, England),
13 Suppl 1(1), S61-72. http://www.ncbi.nlm.nih.gov/pubmed/10546786
García de Olalla, P., Knobel, H., Carmona, A., Guelar, A., Lôpez-Colomés, J. L.,
& Caylà, J. A. (2002). Impact of adherence and highly active antiretroviral
therapy on survival in HIV-infected patients. Journal of Acquired Immune
Deficiency Syndromes, 30(1), 105–110. https://doi.org/10.1097/00126334-
200205010-00014
Goldie, S. J., Paltiel, A. D., Weinstein, M. C., Losina, E., Seage, G. R., Kimmel,
A. D., Walensky, R. P., Sax, P. E., & Freedberg, K. A. (2003). Projecting
the cost-effectiveness of adherence interventions in persons with human
immunodeficiency virus infection. The American Journal of Medicine,
115(8), 632–641.
Hasim, H. (2015). Terapi HIV. MyHealth, Ministry of Health.
Hayes, T. L., Hunt, J. M., Adami, A., & Kaye, J. A. (2006). An Electronic Pillbox
for Continuous Monitoring of Medication Adherence. 2006 International
Conference of the IEEE Engineering in Medicine and Biology Society,
23(1), 6400–6403. https://doi.org/10.1109/IEMBS.2006.260367
Hogg, R. S., Heath, K., Bangsberg, D., Yip, B., Press, N., O’Shaughnessy, M. V.,
& Montaner, J. S. G. (2002). Intermittent use of triple-combination therapy
is predictive of mortality at baseline and after 1 year of follow-up. AIDS,
16(7), 1051–1058. https://doi.org/10.1097/00002030-200205030-00012

62